Health Library

Blood in the semen

Semen - bloody; Blood in ejaculation; Hematospermia

Blood in the semen is called hematospermia. It may be in amounts too small to be seen except with a microscope, or it may be visible in the ejaculation fluid.

Images

I Would Like to Learn About:

Causes

Most of the time, the cause for blood in the semen is not known. It can be caused by swelling or infection of the prostate or seminal vesicles. The problem may occur after a prostate biopsy.

Blood in the semen may also be caused by:

• Blockage due to enlarged prostate (prostate problems)
• Infection of the prostate
• Irritation in the urethra (urethritis)
• Injury to the urethra

Often, the cause of the blood cannot be found.

Sometimes, the visible blood will last several days to weeks, depending on the cause of the blood and if any clots formed in the seminal vesicles.

Depending on the cause, other symptoms that may occur include:

• Blood in the urine
• Fever or chills
• Lower back pain
• Pain with bowel movement
• Pain with ejaculation
• Pain with urination
• Swelling in the scrotum
• Swelling or tenderness in the groin area
• Tenderness in the scrotum

Home Care

The following steps may help ease discomfort from a prostate infection or urinary infection:

• Take over-the-counter pain relievers such as ibuprofen or naproxen.
• Drink plenty of fluids.
• Eat high-fiber foods to make bowel movements easier.

When to Contact a Medical Professional

Always contact your health care provider if you notice any blood in your semen.

What to Expect at Your Office Visit

The provider will perform a physical exam and look for signs of:

• Discharge from the urethra
• Enlarged or tender prostate
• Fever
• Swollen lymph nodes
• Swollen or tender scrotum

You may need the following tests:

• Prostate exam
• PSA blood test
• Semen analysis
• Semen culture
• Ultrasound or MRI of the prostate, pelvis or scrotum
• Urinalysis
• Urine culture

Related Information

References

Cooney KA, Heath EI. Prostate cancer. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 186.

Kaplan SA. Benign prostatic hyperplasia and prostatitis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 114.

Park JH, Leitner DV, Elsamra SE. Evaluation of the urologic patient: history and physical examination. In: Dmochowski RR, Kavoussi LR, Peters CA, et al, eds. Campbell-Walsh-Wein Urology. 13th ed. Philadelphia, PA: Elsevier; 2026:chap 2.

Review Date: 7/1/2025  

Reviewed By: Kelly L. Stratton, MD, FACS, Associate Professor, Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.